— Randomized, double-blind, controlled trial met primary endpoint of durable response rate and all secondary endpoints — — Overall safety consistent…
Acquisition of Bird Rock Bio builds Skye's position as a leading endocannabinoid system-focused pharmaceutical companyNew capital funds anticipated Phase 2a…
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the…
LAS VEGAS, NV / ACCESSWIRE / August 21, 2023 / Cancer Partners of Nebraska, a leading healthcare provider specializing in…
Up to EUR 75M from Kreos Capital and Claret European Growth CapitalUp to EUR 75M from Heights Capital ManagementEUR 27M…
OTTAWA, Aug. 19, 2023 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the British Columbia Fires Appeal to help…
Approval based on the pivotal PULSAR and PHOTON trials in which EYLEA® HD demonstrated clinically equivalent vision gains to EYLEA…
Registration with Red Cross ensures people can be notified as services may become availableOTTAWA, Aug. 18, 2023 (GLOBE NEWSWIRE) --…
Irvine, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Results The Company reported net income of $176,427 or $0.01 per basic and…
VANCOUVER, BC / ACCESSWIRE / August 18, 2023 / EMPOWER CLINICS INC (CSE:EPW)(OTC PINK:EPWCF) ("Empower" or the "Company") an integrated…